Medicare Advantage: Growth Amidst Mounting Scrutiny
Our Take: A 2023 commentary in the Journal of the American Board of Family Medicine reviews escalating federal oversight of the Medicare Advantage program, citing GAO auditing concerns, a congressional hearing on plan…